MONTREAL, QUEBEC--(Marketwire - December 15, 2008) - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it has entered into an automatic share purchase plan with a broker in order to facilitate repurchases of its common shares under its normal course issuer bid. Paladin previously announced that it had received approval from the Toronto Stock Exchange (“TSX”) to make a normal course issuer bid to purchase up to 786,000 common shares, being approximately 10% of its public float of 7,867,694 common shares as at February 15, 2008. The normal course issuer bid commenced on March 3, 2008 and will terminate on March 2, 2009, or such earlier date as Paladin may complete repurchases under the bid.
